Form 8-K Xenon Pharmaceuticals For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Xenon Pharmaceuticals (XENE) Misses Q3 EPS by 25c
November 10, 2015 4:38 PM ESTXenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.27), $0.25 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $4.29 million versus the consensus estimate of $4.65 million.
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
... More